Physician

Omesh Parkash Gupta, MD

According to 2025 Medicare claims, Omesh Gupta, MD (NPI: 1326268475) practices ophthalmology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Montgomery, PA. This provider's primary affiliated billing organization is RETINOVITREOUS ASSOCIATES LTD (NPI: 1659326452; TIN: 231932869) and primary practice location at 08053-3425.

Gupta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,884 traditional Medicare patients, billed 43,259 HCPCS/CPT codes, and received $6,796,256 in Medicare payments. The top billing code was Q5128 (Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg). Part D data shows 1,604 prescription claims across 418 beneficiaries totaling $137,696 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 8 records totaling $23,851. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $4,138,330 to $6,796,256. Similarly, Part D prescription costs have risen steadily, from $88,151 to $137,696. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$4.0M$8.0M2015 Medicare payment: $4,138,330 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $4,645,196 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $5,235,781 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $6,722,512 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $7,494,233 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $7,793,707 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $7,964,364 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $7,605,494 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $7,218,559 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $6,796,256 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,81020,439$4,138,330
20161,92221,949$4,645,196
20171,90324,151$5,235,781
20182,21033,290$6,722,512
20192,25937,273$7,494,233
20202,05738,624$7,793,707
20212,11141,537$7,964,364
20222,22542,477$7,605,494
20232,10144,322$7,218,559
20241,88443,259$6,796,256

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$88K$177K2015 Drug cost: $88,151 (USD; Tot_Drug_Cst)2016 Drug cost: $105,033 (USD; Tot_Drug_Cst)2017 Drug cost: $132,212 (USD; Tot_Drug_Cst)2018 Drug cost: $159,244 (USD; Tot_Drug_Cst)2019 Drug cost: $166,922 (USD; Tot_Drug_Cst)2020 Drug cost: $172,259 (USD; Tot_Drug_Cst)2021 Drug cost: $159,602 (USD; Tot_Drug_Cst)2022 Drug cost: $176,632 (USD; Tot_Drug_Cst)2023 Drug cost: $167,780 (USD; Tot_Drug_Cst)2024 Drug cost: $137,696 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152991,048$88,151
20162931,089$105,033
20172901,263$132,212
20183321,350$159,244
20193851,455$166,922
20203441,399$172,259
20213921,511$159,602
20224121,549$176,632
20234321,646$167,780
20244181,604$137,696

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
Q5128Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg44018,534$180
67028Injection of drug into eye6384,866$102
92014Established patient complete exam of visual system9311,100$94
92012Established patient problem focused exam of visual system9604,246$73
92134Imaging of retina1,8086,853$33

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium1114,787$46,190
Prednisolone AcetatePrednisolone Acetate38714,355$18,401
Bromfenac SodiumBromfenac Sodium913,570$16,262
IlevroNepafenac28550$11,140
Brimonidine TartrateBrimonidine Tartrate874,295$3,338

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$18,758Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.1$5,094Alcon Research LLC
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Omesh Parkash Gupta, MD?

Tedicare shows public-source Medicare data for Omesh Parkash Gupta, MD (NPI 1326268475), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Omesh Parkash Gupta, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Omesh Parkash Gupta, MD?

Omesh Parkash Gupta, MD is linked to RETINOVITREOUS ASSOCIATES LTD (billing NPI 1659326452) in the available physician profile data.

Does Omesh Parkash Gupta, MD have Open Payments data?

Omesh Parkash Gupta, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.